Vertex Pharmaceuticals Incorporated
VRTX
$493.84
$1.370.28%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -6.26% | 12.58% | -43.02% | -9.33% | -5.95% |
Total Receivables | -8.07% | 5.71% | -7.65% | 14.70% | 1.61% |
Inventory | 11.63% | 18.06% | 12.48% | 10.06% | 7.27% |
Prepaid Expenses | 4.67% | -16.99% | 11.64% | -11.94% | 8.39% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 1,866.67% | -77.61% | 24.40% | -56.21% | 94.80% |
Total Current Assets | -2.12% | 9.65% | -32.71% | -6.05% | -3.75% |
|
|||||
Total Current Assets | -2.12% | 9.65% | -32.71% | -6.05% | -3.75% |
Net Property, Plant & Equipment | 2.81% | 41.97% | 19.18% | 2.26% | 1.28% |
Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Intangibles | -0.69% | -0.70% | 0.31% | -0.60% | 39.15% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1.26% | 6.93% | 9.10% | 2.11% | 28.57% |
Total Assets | 1.32% | 10.47% | -15.83% | 5.22% | 4.62% |
|
|||||
Total Accounts Payable | 4.35% | 20.71% | -6.69% | -3.70% | -2.93% |
Total Accrued Expenses | -18.39% | 9.51% | 5.15% | 9.39% | -12.09% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 29.63% | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 50.77% | 2.54% | -56.94% | 19.45% | 71.73% |
Total Other Current Liabilities | 50.77% | 2.54% | -56.94% | 19.45% | 71.73% |
Total Current Liabilities | -10.28% | 12.01% | -6.55% | 7.01% | -1.44% |
|
|||||
Total Current Liabilities | -10.28% | 12.01% | -6.55% | 7.01% | -1.44% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -2.68% | 82.44% | 29.41% | -0.47% | -2.69% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -3.38% | 6.44% | 2.72% | -2.75% | 0.97% |
Total Liabilities | -7.35% | 23.37% | -0.25% | 4.29% | -1.22% |
|
|||||
Common Stock & APIC | -3.38% | -2.75% | -2.52% | -2.21% | 1.50% |
Retained Earnings | 10.50% | 13.67% | -31.97% | 10.84% | 10.56% |
Treasury Stock & Other | 343.75% | 28.00% | 30.06% | 220.98% | -376.67% |
Total Common Equity | 4.98% | 5.80% | -20.34% | 5.50% | 6.47% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 4.98% | 5.80% | -20.34% | 5.50% | 6.47% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 4.98% | 5.80% | -20.34% | 5.50% | 6.47% |
|